文献速递中毒与环境急症心脑血管急症

神经颗粒素对一氧化碳中毒患者的诊断价值:能否显示早期神经损伤?

The diagnostic value of neurogranin in patients with carbon monoxide poisoning: Can it show early neurological damage?
PubMed 文献 · Am J Emerg Med · 2021-07-27
一句话结论一氧化碳中毒患者血清神经颗粒素显著高于健康对照,且弥散加权成像正常者仍可升高,提示其或可辅助识别影像阴性的早期神经损伤。

该前瞻性研究纳入36例急诊一氧化碳中毒患者与32名健康对照,比较血清神经颗粒素水平。患者组神经颗粒素为0.31±0.16 ng/ml,显著高于对照组的0.22±0.10 ng/ml(p=0.015)。患者组平均格拉斯哥昏迷评分为14.59±0.23,94.4%(34/36)弥散加权磁共振成像完全正常,且神经颗粒素水平与弥散加权成像结果无相关性(r=-0.011;p=0.953)。作者认为神经颗粒素可能是急诊一氧化碳中毒的新诊断生物标志物,影像正常者其升高提示存在影像无法检出的神经损伤。

要点

  • 急诊一氧化碳中毒患者血清神经颗粒素0.31±0.16 ng/ml,显著高于健康对照0.22±0.10 ng/ml(p=0.015)。
  • 中毒患者平均格拉斯哥昏迷评分14.59±0.23,94.4%(34/36)弥散加权磁共振成像完全正常。
  • 血清神经颗粒素水平与弥散加权磁共振成像结果无相关性(r=-0.011;p=0.953)。
  • 作者提出:影像正常的中毒患者神经颗粒素升高,可能提示影像无法检出的神经损伤。

适用人群与场景

  • 急诊科收治的一氧化碳中毒患者(患者组n=36)与健康志愿者(对照组n=32)。
  • 原文未明确列出纳入/排除标准的具体条目。

诊断标准与关键阈值

  • 原文未提及神经颗粒素的诊断界值、启动或停止阈值。
  • 患者组平均格拉斯哥昏迷评分为14.59±0.23。
  • 94.4%(34/36)患者弥散加权磁共振成像结果完全正常。

处置流程与药物剂量

  • 原文未提及基于神经颗粒素的具体处置流程或药物剂量。

红旗征与不能漏的情况

  • 原文未提及需要立刻处理或不能漏诊的具体红旗征及对应处理。

研究设计与关键结果

  • 主要结果:患者组血清神经颗粒素0.31±0.16 ng/ml,显著高于对照组0.22±0.10 ng/ml(p=0.015)。
  • 患者组平均格拉斯哥昏迷评分14.59±0.23;94.4%(n=34)弥散加权磁共振成像完全正常。
  • 神经颗粒素水平与弥散加权磁共振成像结果无相关性(r=-0.011;p=0.953)。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据等级或推荐强度:原文未给出。
  • 局限:样本量小、单中心、对照组为健康志愿者而非其他急诊中毒患者,神经颗粒素与影像无相关性,诊断阈值未建立。

对床旁实践的改变

  • 原文提示神经颗粒素可能作为急诊一氧化碳中毒的辅助诊断生物标志物,但尚未提供可用于床旁决策的阈值。
  • 对于弥散加权磁共振成像正常的一氧化碳中毒患者,神经颗粒素升高可能提示影像无法检出的神经损伤,但原文未给出据此改变处理的方案。
  • 不适用人群:原文未明确排除人群;健康对照数据不能直接外推为急诊鉴别诊断阈值。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND AND AIM: Carbon monoxide poisoning is a toxicological emergency that causes neurological complications. High serum neurogranin can be detected in acute or chronic conditions where brain tissue is damaged. This study aimed to investigate the diagnostic value of serum neurogranin level and its role in demonstrating neurological damage in patients admitted to the emergency department with carbon monoxide poisoning.

MATERIALS AND METHODS: The study was conducted prospectively on patients with carbon monoxide poisoning (patient group) and healthy volunteers (control group). Demographic characteristics and serum neurogranin level of all participants and symptoms at admission, neurological examination findings, laboratory results, and Diffusion-Weighted Magnetic Resonance Imaging results of the patient group were recorded. We used an independent sample t-test to compare neurogranin levels and bivariate correlation analysis to compare the relationship between serum neurogranin levels and data belonging to the patient group.

RESULTS: Sixty eight participants (patient group, n = 36; control group, n = 32) were included in the study. Serum neurogranin level was significantly higher in patients with carbon monoxide poisoning (0.31 ± 0.16 ng/ml) compared to control group (0.22 ± 0.10 ng/ml) (p = 0.015). The mean Glasgow Coma Scale of the patients with carbon monoxide poisoning was 14.59 ± 0.23, and of Diffusion Weighted Magnetic Resonance Imaging results were completely normal in 94.4% (n = 34). There was no correlation between serum neurogranin level and Diffusion Weighted Magnetic Resonance Imaging results (r = -0.011; p = 0.953).

CONCLUSION: Serum neurogranin level may be a new diagnostic biomarker in patients admitted to the emergency department with carbon monoxide poisoning. The high serum neurogranin levels detected in patients with normal diffusion-weighted imaging after carbon monoxide poisoning suggest that there is neurological damage in these patients, even if imaging methods cannot detect it.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Yeşilyurt Ö, Cömertpay E, Vural S, et al. The diagnostic value of neurogranin in patients with carbon monoxide poisoning: Can it show early neurological damage? Am J Emerg Med. 2021. PMID: 34388687. doi:10.1016/j.ajem.2021.07.052

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。